Fri, Aug 22, 2014, 5:19 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Intuitive Surgical, Inc. Message Board

  • megapicki megapicki Oct 2, 2013 12:22 PM Flag

    EDAP (MC $56 M) FDA approval for Prostate Cancer Cure in 1Q 2014 =500%++ Potential !!!

    A LIFETIME OPPRTUNITY HERE GUYS ...

    This Undiscovered Gem is brutally Cheap and has Monster Upside Potential especially on the Upcoming FDA approval (1Q14) of Ablatherm-Hifu an very effective treatment for localized prostate cancer .

    FDA approval + Low float = $12-15 within next Year . Please Do your own DD to realize the Full Potential in this Goldmine .GLTA

    EDAP

    Market Cap: $56 M
    Cash: $10 M
    Price: $2,50
    DEBT FREE

    Shares Out: 21,7 M

    Ablatherm-HIFU a treatment for prostate cancer is currently under regulatory review in the U.S. following submission of the Pre-Market Approval Application in February 2013 after the completion of a multi-center U.S. Phase II/III clinical trial under an Investigational Device Exemption (IDE) granted by the FDA.

    Marc Oczachowski, EDAP’s chief executive officer, continued, “Therapeutic ultrasound is gradually gaining ground in cancer treatment approach. We clearly see a growing interest in minimally invasive focal therapies for cancer tumors. Our 20 years expertise in the treatment of localized prostate cancer using HIFU has long been demonstrated and we are excited to further participate in the development of such new projects aiming at improving cancer drug delivery. While we expand our expertise in HIFU to further applications, we remain fully focused on developing our HIFU technology and adapt it to the current focal therapy trend to treat prostate cancers. We believe that the focal therapy approach represents a unique opportunity for Ablatherm HIFU to become the gold standard of treatment for prostate cancer.”
    -

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Here are 2 comments from the Accuray (ARAY) message board About Ablattherm HIFU as a treatment for prostate cancer...

      The first is by lamb_to_slaughter, an Oncoligist:

      "The FDA has not approved the use of HIFU for prostate cancer, but that has not prevented otherwise good urologists I know from personally flying pts to Cancun or the Dominican Republic for such treatment for 30K cash, with 8K going to the urologist. Since they would take 3 pts at a time it's not a bad way to spend a weekend in Cancun. It's a disgrace, but it illustrates what I've been trying to say on this board (and how convincing urologists can be to pts - these guys which 30K to spend are not idiots).
      __

      I am hardly an expert on HIFU. I only hear second hand from my urologists who see pts who had HIFU. They say the incidence and intensity of pelvic/perineal pain is underreported, that catheters must be used for at least 2 weeks, that obstruction from necrotic tissue can occur for several months post-tx, and that impotence and short-term incontinence are common."

      And another from still_one:

      "It is more invasive. In addition, if you are talking about PCa, it is not feasible for large prostates.

      It also requires general anesthesia, and an overnight hospital stay. There is also a lot more data on external radiation, including cyberknife than HIFU. From what I have seen data is mixed anedotely on HIFU compared to cyberknife or other forms of photon or proton radiation. "

 
ISRG
471.74-0.15(-0.03%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.